2025. June 12., Thursday
Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar

University of Szeged
Albert Szent-Györgyi Medical School
 
Foreign Students' Secretariat




Your Education. Our Mission.

0

Dr. Levente Szalárdy: Doctor, researcher and composer

Levente Szalárdy has been playing the guitar, violin, piano and folk flutes since childhood and he also founded a folk dance group, but in the end he did not choose music as his career.

Levente Szalárdy has been playing the guitar, violin, piano and folk flutes since childhood and he also founded a folk dance group, but in the end he did not choose music as his career. He became an assistant professor at the Department of Neurology, University of Szeged and he has also been awarded the Junior Prima Prize as a researcher. (This award recognizes outstanding performance of young scientists, whose career has been distinguished by outstanding international results, a continued commitment to excellence in endeavors of science, research, and education in Hungary). The reason for our interview is his debut as the composer of a dance drama.


Music has played a very important role in your life since childhood. Why did you choose medicine then?


I grew up in a family of teachers, where everyone is a musician as well. My mother was a piano teacher, my father taught history, played the guitar and did a lot of concerts in the Beat era. I played the violin for 12 years, learnt to play the guitar and the piano, and all string instruments are very close to my heart. By the time I started high school, we had a band performing poems set to music all over the country. During my high school years, I considered becoming a full-time musician, but eventually chose medicine, However, I kept on performing at concerts during university. I had always planned to become a surgeon, but in the fifth year I was drawn to Neurology. First, I worked as a researcher at the department and then became a clinician after completing my PhD.


1


You were a full-time researcher for three years. What was this research about and what are you working on now?


My PhD work was basically a detailed pathophysiological characterization of the nervous system of a genetically modified mouse strain, as well as a study of their cognitive and motor behavior. This way, we were able to describe a model of mitochondrial brain disorders, which was a long-awaited achievement. The other area in which I started research was the identification of so-called biomarkers in the human CSF that could facilitate the diagnosis or predict the course of the disease. First, I focused on multiple sclerosis, then my interest shifted to stroke care, including hemorrhagic strokes, and this is still my main area of interest. I felt that this group of diseases was somehow neglected even though it has a significant overlap with neurodegenerative disorders involving the progressive death of certain brain cells, therefore it is related to my previous work. My scientific activity is currently focused on this cerebral amyloid angiopathy.


How is it related to your work as a specialist at the Department of Neurology?


My short-term goal is to diagnose this group of diseases in the simplest and fastest way, possibly before the disease has reached a stage where the quality of life is already deteriorating. This would be very important, as cerebral amyloid angiopathy is responsible for a significant proportion of strokes in old age. The long-term goal is to identify potential therapeutic options that could effectively prevent the progression of this disease.


2


With all this work, how do you now fit music and composition into your life?


It's not easy, I have to make time for music in the evenings, at night or at weekends besides my work at the department, research and family. Just as I needed a solid background during my PhD, I need the same type of background for music now. I would not be able to manage otherwise. It is my wife I couldn't do without; she's the one who looks after our two children and carries the family on her shoulders. Nowadays, music mostly means composing for theatre performances, in fact as project work.


Working on each performance starts by talking through the events, actions and situations that make up the play to see what kind of atmosphere, mood or image I need to create through the music, how it helps to portray the change of characters or events. Once I have the basic framework of the interpretation, I start working more closely with the choreographer. After we have agreed on our concept, I'll go off and spend the last 3-4 months with my fellow musicians and myself until we get into the studio. I have to capture the inner emotional mood and help with portraying it on the stage.


What do you get from music? Is it connected in any way to medicine?


You need perfectionism for both of them, because it always moves you forward. It's for the benefit of the patient if I double-check everything I've done, but it's also for quality in science, as well as in music. What scientific publications and composing music have in common is thinking in units. You have to see where you started from and where you are going, you need to have an arc to the whole so that you don't lose the reader in the case of publication and the listener in the case of music. It is important that the viewer can be drawn into the piece, and music plays a big part in that.


Latest news

SZTE-MSD_egyuttmukodesi_megallapodas_alairas_2

The University of Szeged and MSD have established a joint Pharmaceutical Industry Partnership Department, marking a new chapter in their collaboration. This initiative builds on a long-standing partnership – further strengthened in 2023 through clinical trial cooperation – and seeks to foster innovation in research, education, and pharmaceutical development. The agreement was officially signed in Szeged by Prof. Dr. László Rovó, Rector of the University of Szeged; Prof. Dr. Ildikó Csóka, Director-General for Strategic Planning; Prof. Dr. Zsolt Szakonyi, Dean of the Faculty of Pharmacy; Sean R. Smith, Managing Director of MSD Pharma Hungary Kft.; and Dr. Szabolcs Barótfi, Director of Clinical Research at MSD Hungary.

083a6605

On May 12, the University of Szeged held an official ceremony to inaugurate its new research unit: the Host–Pathogen Interaction Center. Located within the Institute of Biology, the Center features Hungary’s only in vivo experimental station of its kind, alongside five newly renovated laboratories. This state-of-the-art facility is designed to support the development of antimicrobial therapies, with a particular focus on antifungal treatments – addressing a pressing yet often overlooked public health concern. The project was made possible through both professional and financial support from Katalin Karikó, an SZTE alumna and recipient of the 2023 Nobel Prize in Physiology or Medicine.

KJA-Number-0879

The origins of the University of Szeged date back to May 12, 1581, when István Báthory established the Jesuit College in Cluj-Napoca – an institution recognized as SZTE's legal predecessor. Exactly 444 years later, the University marked this anniversary with a symbolic “birthday gift”: the signing of two strategic partnership agreements. Supported by two of South America’s leading scientific and healthcare institutions, these partnerships are set to position SZTE among the global research elite in emerging and internationally significant fields of healthcare research and education.